Noninvasive evaluation of nonalcoholic steatohepatitis (NASH)

被引：1
作者：
Mansour-Ghanaei, Fariborz [1 ]
Vahhabi-Moghaddam, Masrour [2 ]
Joukar, Farahnaz [1 ]
Asgharnezhad, Mehrnaz [1 ]
Kiyani, Noufar [2 ]
机构：
[1] Guilan Univ Med Sci, GLDRC, Rasht, Iran
[2] Guilan Univ Med Sci, Poursina Hosp, Dept Radiol, Rasht, Iran
来源：
CASPIAN JOURNAL OF INTERNAL MEDICINE | 2013年 / 4卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：797 / 798
页数：2
相关论文
共 50 条
  • [31] Noninvasive diagnosis of nonalcoholic steatohepatitis: Emerging approaches
    Pan, Qin
    Fan, Jian-Gao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (01) : 1 - 3
  • [32] A CLINICAL NONINVASIVE METHOD FOR THE DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
    POPPLEWELL, L
    PEIRIS, AN
    STAGNER, JI
    TAMBURRO, CH
    HEPATOLOGY, 1992, 16 (02) : 584 - 584
  • [33] Noninvasive diagnosis of nonalcoholic steatohepatitis using elastometry
    Takeda, Tadashi
    Yasuda, Takahiro
    Kimura, Megumi
    Nakaya, Mika
    Fujii, Hideki
    Nakayama, Yuji
    Sakaguchi, Hideki
    Seki, Shuichi
    HEPATOLOGY, 2006, 44 (04) : 652A - 652A
  • [34] Noninvasive Assessment of Nonalcoholic Steatohepatitis and Nonalcoholic Steatohepatitis-Related Fibrosis: Is There a Role for Cytokeratin 18?
    Xanthakos, Stavra A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 63 (02) : 167 - 168
  • [35] Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography
    Tsai, Eugenia
    Lee, Tai-Ping
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 73 - +
  • [36] Predicting nonalcoholic steatohepatitis (NASH) using mechanistic biomarkers
    Tan, Eunice
    Jumat, Nur Halisa
    Soon, Gwyneth Shook Ting
    Lee, Jonathan Wei Jie
    Dan, Yock Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 425 - 425
  • [37] Insulin Resistance, Reason or Consequence Nonalcoholic Steatohepatitis (NASH)
    Akbari, Hamed
    Vakili, Sina
    Aria, Hamid
    Taghadosi, Roholah
    Alavi, Seyed Ali
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (03): : 1861 - 1865
  • [38] Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
    Van Meeteren, Menso J. Westerouen
    Drenth, Joost P. H.
    Tjwa, Eric T. T. L.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (02) : 117 - 123
  • [39] Cells to Prevent the Development and Progression of Nonalcoholic Steatohepatitis (NASH)
    Sun, Guangyong
    Zhang, Chunpan
    Jin, Hua
    Shi, Wen
    Wang, Tianqi
    Zhang, Dong
    HEPATOLOGY, 2018, 68 : 64A - 64A
  • [40] Innate immunity involved in the pathogenesfs of nonalcoholic steatohepatitis (NASH)
    不详
    LIVER TRANSPLANTATION, 2006, 12 (10) : 1553 - 1554
12345